Kevin Fischbeck
Stock Analyst at B of A Securities
(4.00)
# 572
Out of 5,139 analysts
189
Total ratings
66.42%
Success rate
5.85%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPCH Option Care Health | Maintains: Buy | $32 → $35 | $36.03 | -2.86% | 2 | Dec 9, 2025 | |
| ACHC Acadia Healthcare Company | Downgrades: Underperform | $22 → $13 | $11.68 | +11.30% | 9 | Dec 3, 2025 | |
| ARDT Ardent Health | Maintains: Underperform | $12 → $10 | $8.60 | +16.28% | 4 | Nov 13, 2025 | |
| HUM Humana | Maintains: Neutral | $280 → $300 | $273.28 | +9.78% | 17 | Oct 10, 2025 | |
| ELV Elevance Health | Maintains: Neutral | $330 → $370 | $374.87 | -1.30% | 4 | Oct 10, 2025 | |
| UNH UnitedHealth Group | Maintains: Neutral | $350 → $390 | $331.02 | +17.82% | 27 | Oct 8, 2025 | |
| AMN AMN Healthcare Services | Maintains: Underperform | $20 → $18 | $19.02 | -5.36% | 5 | Sep 10, 2025 | |
| DVA DaVita | Maintains: Underperform | $145 → $140 | $104.74 | +33.66% | 13 | Sep 10, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $205 → $225 | $196.74 | +14.36% | 7 | Sep 10, 2025 | |
| EHC Encompass Health | Maintains: Buy | $145 → $160 | $100.50 | +59.20% | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $30 | $45.75 | -34.43% | 13 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $215 → $185 | $199.88 | -7.44% | 15 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $394 → $410 | $469.29 | -12.63% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $3 | $1.02 | +194.12% | 2 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $191.40 | +129.36% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $10.61 | -38.74% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $22.50 | -67.78% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $272.21 | +28.58% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $15.90 | +183.02% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $3.20 | +71.88% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $15.36 | +127.86% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $2.54 | +293.70% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $9.16 | -18.12% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $21.86 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $26.38 | -27.98% | 2 | Feb 9, 2018 |
Option Care Health
Dec 9, 2025
Maintains: Buy
Price Target: $32 → $35
Current: $36.03
Upside: -2.86%
Acadia Healthcare Company
Dec 3, 2025
Downgrades: Underperform
Price Target: $22 → $13
Current: $11.68
Upside: +11.30%
Ardent Health
Nov 13, 2025
Maintains: Underperform
Price Target: $12 → $10
Current: $8.60
Upside: +16.28%
Humana
Oct 10, 2025
Maintains: Neutral
Price Target: $280 → $300
Current: $273.28
Upside: +9.78%
Elevance Health
Oct 10, 2025
Maintains: Neutral
Price Target: $330 → $370
Current: $374.87
Upside: -1.30%
UnitedHealth Group
Oct 8, 2025
Maintains: Neutral
Price Target: $350 → $390
Current: $331.02
Upside: +17.82%
AMN Healthcare Services
Sep 10, 2025
Maintains: Underperform
Price Target: $20 → $18
Current: $19.02
Upside: -5.36%
DaVita
Sep 10, 2025
Maintains: Underperform
Price Target: $145 → $140
Current: $104.74
Upside: +33.66%
Tenet Healthcare
Sep 10, 2025
Maintains: Buy
Price Target: $205 → $225
Current: $196.74
Upside: +14.36%
Encompass Health
Sep 10, 2025
Maintains: Buy
Price Target: $145 → $160
Current: $100.50
Upside: +59.20%
Jul 16, 2025
Downgrades: Underperform
Price Target: $52 → $30
Current: $45.75
Upside: -34.43%
Jul 16, 2025
Downgrades: Underperform
Price Target: $215 → $185
Current: $199.88
Upside: -7.44%
Jul 16, 2025
Downgrades: Neutral
Price Target: $394 → $410
Current: $469.29
Upside: -12.63%
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $1.02
Upside: +194.12%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $191.40
Upside: +129.36%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $10.61
Upside: -38.74%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $22.50
Upside: -67.78%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $272.21
Upside: +28.58%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $15.90
Upside: +183.02%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $3.20
Upside: +71.88%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $15.36
Upside: +127.86%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $2.54
Upside: +293.70%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $9.16
Upside: -18.12%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $21.86
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $26.38
Upside: -27.98%